1. Baratti, Dario, Shigeki Kusamura, Daisuke Nonaka, Martin Langer, Salvatore Andreola, Miriam Favaro, Cecilia Gavazzi, Barbara Laterza, et Marcello Deraco. 2008. « Pseudomyxoma Peritonei: Clinical Pathological and Biological Prognostic Factors in Patients Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) ». Annals of Surgical Oncology 15(2): 526‑34. doi:10.1245/s10434-007-9691-2.
  2. Bijelic, Lana, Anjali S. Kumar, O. Anthony Stuart, et Paul H. Sugarbaker. 2012. « Systemic Chemotherapy Prior to Cytoreductive Surgery and HIPEC for Carcinomatosis from Appendix Cancer: Impact on Perioperative Outcomes and Short-Term Survival ». Gastroenterology Research and Practice 2012: 163284. doi:10.1155/2012/163284.
  3. Borazanci, Erkut, Sherri Z. Millis, Jeffery Kimbrough, Nancy Doll, Daniel Von Hoff, et Ramesh K. Ramanathan. 2017. « Potential actionable targets in appendiceal cancer detected by immunohistochemistry, fluorescent in situ hybridization, and mutational analysis ». Journal of Gastrointestinal Oncology 8(1): 164‑72. doi:10.21037/jgo.2017.01.14.
  4. Bouquot, Morgane, Anthony Dohan, Etienne Gayat, Maxime Barat, Olivier Glehen, Marc Pocard, Pascal Rousset, et Clarisse Eveno. 2018. « Prediction of Resectability in Pseudomyxoma Peritonei with a New CT Score ». Annals of Surgical Oncology 25(3): 694‑701. doi:10.1245/s10434-017-6275-7.
  5. Bradley, Robert F., John H. Stewart, Gregory B. Russell, Edward A. Levine, et Kim R. Geisinger. 2006. « Pseudomyxoma Peritonei of Appendiceal Origin: A Clinicopathologic Analysis of 101 Patients Uniformly Treated at a Single Institution, with Literature Review ». The American Journal of Surgical Pathology 30(5): 551‑59. doi:10.1097/01.pas.0000202039.74837.7d.
  6. Carr, Norman J., Frederic Bibeau, Robert F. Bradley, Peggy Dartigues, Roger M. Feakins, Kim R. Geisinger, Xianyong Gui, et al. 2017. « The Histopathological Classification, Diagnosis and Differential Diagnosis of Mucinous Appendiceal Neoplasms, Appendiceal Adenocarcinomas and Pseudomyxoma Peritonei ». Histopathology 71(6): 847‑58. doi:10.1111/his.13324.
  7. Carr, Norman J., Thomas D. Cecil, Faheez Mohamed, Leslie H. Sobin, Paul H. Sugarbaker, Santiago González-Moreno, Panos Taflampas, Sara Chapman, et Brendan J. Moran. 2016. « A Consensus for Classification and Pathologic Reporting of Pseudomyxoma Peritonei and Associated Appendiceal Neoplasia: The Results of the Peritoneal Surface Oncology Group International (PSOGI) Modified Delphi Process ». The American Journal of Surgical Pathology 40(1): 14. doi:10.1097/PAS.0000000000000535.
  8. Choe, J. H., M. J. Overman, K. F. Fournier, R. E. Royal, A. Ohinata, S. Rafeeq, K. Beaty, et al. 2015. « Improved Survival with Anti-VEGF Therapy in the Treatment of Unresectable Appendiceal Epithelial Neoplasms ». Annals of Surgical Oncology 22(8): 2578‑84. doi:10.1245/s10434-014-4335-9.
  9. Chua, T. C., B. J. Moran, P. H. Sugarbaker, E. A. Levine, O. Glehen, F. N. Gilly, D. Baratti, et al. 2012. « Early- and Long-Term Outcome Data of Patients With Pseudomyxoma Peritonei From Appendiceal Origin Treated by a Strategy of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy ». Journal of Clinical Oncology 30(20): 2449‑56. doi:10.1200/JCO.2011.39.7166.
  10. Chua, Terence C., Winston Liauw, et David L. Morris. 2012. « Early Recurrence of Pseudomyxoma Peritonei Following Treatment Failure of Cytoreductive Surgery and Perioperative Intraperitoneal Chemotherapy Is Indicative of a Poor Survival Outcome ». International Journal of Colorectal Disease 27(3): 381‑89. doi:10.1007/s00384-011-1303-8.
  11. Clift, Ashley K, Oskar Kornasiewicz, Panagiotis Drymousis, Omar Faiz, Harpreet S Wasan, James M Kinross, Thomas Cecil, et Andrea Frilling. 2018. « Goblet cell carcinomas of the appendix: rare but aggressive neoplasms with challenging management ». Endocrine Connections 7(2): 268‑77. doi:10.1530/EC-17-0311.
  12. Dartigues, Peggy, Vahan Kepenekian, Claire Illac-Vauquelin, Véronique Verriele, Juliette Fontaine, Sylvie Isaac, Anne Chevallier, et al. 2025. « Insights into the Clinical Prognosis of High-Grade Appendiceal Mucinous Neoplasms ». The American Journal of Surgical Pathology. doi:10.1097/PAS.0000000000002373.
  13. Dohan, A., C. Hobeika, H. Najah, M. Pocard, P. Rousset, et C. Eveno. 2018. « Preoperative Assessment of Peritoneal Carcinomatosis of Colorectal Origin ». Journal of Visceral Surgery 155(4): 293‑303. doi:10.1016/j.jviscsurg.2018.01.002.
  14. Dohan, A., C. Hoeffel, P. Soyer, A. S. Jannot, P.-J. Valette, A. Thivolet, G. Passot, O. Glehen, et P. Rousset. 2017. « Evaluation of the Peritoneal Carcinomatosis Index with CT and MRI ». The British Journal of Surgery 104(9): 1244‑49. doi:10.1002/bjs.10527.
  15. Durot, C., P. Rousset, A. Thivolet, G. Passot, S. Deguelte, A. Dohan, O. Glehen, et C. Hoeffel. 2018. « What the Radiologist Should Know about Postoperative MDCT Evaluation of a Patient Treated with Cytoreductive Surgery with or without Hyperthermic Intraperitoneal Chemotherapy ». Clinical Radiology 73(6): 517‑25. doi:10.1016/j.crad.2018.02.001.
  16. Farquharson, A. L., N. Pranesh, G. Witham, R. Swindell, M. B. Taylor, A. G. Renehan, S. Rout, et al. 2008. « A Phase II Study Evaluating the Use of Concurrent Mitomycin C and Capecitabine in Patients with Advanced Unresectable Pseudomyxoma Peritonei ». British Journal of Cancer 99(4): 591‑96. doi:10.1038/sj.bjc.6604522.
  17. Foster, Jason M., Richard L. Sleightholm, Steve Wahlmeier, Brian Loggie, Poonam Sharma, et Asish Patel. 2016. « Early Identification of DPAM in At-Risk Low-Grade Appendiceal Mucinous Neoplasm Patients: A New Approach to Surveillance for Peritoneal Metastasis ». World Journal of Surgical Oncology 14(1): 243. doi:10.1186/s12957-016-0996-0.
  18. Fournier, Keith, Safia Rafeeq, Melissa Taggart, Paul Kanaby, Jing Ning, Hsiang-Chun Chen, Michael Overman, et al. 2017. « Low-Grade Appendiceal Mucinous Neoplasm of Uncertain Malignant Potential (LAMN-UMP): Prognostic Factors and Implications for Treatment and Follow-Up ». Annals of Surgical Oncology 24(1): 187‑93. doi:10.1245/s10434-016-5588-2.
  19. Gillion, J.-F., D. Franco, O. Chapuis, D. Serpeau, J.-P. Convard, M.-C. Jullès, A. Balaton, et al. 2009. « [Appendiceal mucoceles, pseudomyxoma peritonei and appendiceal mucinous neoplasms: update on the contribution of imaging to choice of surgical approach] ». Journal De Chirurgie 146(2): 150‑66. doi:10.1016/j.jchir.2009.05.020.
  20. González-Moreno, S., E. Brun, et P. H. Sugarbaker. 2005. « Lymph Node Metastasis in Epithelial Malignancies of the Appendix with Peritoneal Dissemination Does Not Reduce Survival in Patients Treated by Cytoreductive Surgery and Perioperative Intraperitoneal Chemotherapy ». Annals of Surgical Oncology 12(1): 72‑80. doi:10.1007/s10434-004-1161-5.
  21. González-Moreno, S., et P. H. Sugarbaker. 2004. « Right Hemicolectomy Does Not Confer a Survival Advantage in Patients with Mucinous Carcinoma of the Appendix and Peritoneal Seeding ». The British Journal of Surgery 91(3): 304‑11. doi:10.1002/bjs.4393.
  22. Govaerts, K., R. J. Lurvink, I. H. J. T. De Hingh, K. Van der Speeten, L. Villeneuve, S. Kusamura, V. Kepenekian, et al. 2021. « Appendiceal Tumours and Pseudomyxoma Peritonei: Literature Review with PSOGI/EURACAN Clinical Practice Guidelines for Diagnosis and Treatment ». European Journal of Surgical Oncology: The Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 47(1): 11‑35. doi:10.1016/j.ejso.2020.02.012.
  23. Guaglio, Marcello, Snita Sinukumar, Shigeki Kusamura, Massimo Milione, Filippo Pietrantonio, Luigi Battaglia, Stefano Guadagni, Dario Baratti, et Marcello Deraco. 2018. « Clinical Surveillance After Macroscopically Complete Surgery for Low-Grade Appendiceal Mucinous Neoplasms (LAMN) with or Without Limited Peritoneal Spread: Long-Term Results in a Prospective Series ». Annals of Surgical Oncology 25(4): 878‑84. doi:10.1245/s10434-017-6305-5.
  24. Hatch, Quinton M., et Erin W. Gilbert. 2018. « Appendiceal Neoplasms ». Clinics in Colon and Rectal Surgery 31(5): 278‑87. doi:10.1055/s-0038-1642051.
  25. Honoré, Charles, Francesco Caruso, Peggy Dartigues, Léonor Benhaim, Mircea Chirica, Diane Goéré, et Dominique Elias. 2015. « Strategies for Preventing Pseudomyxoma Peritonei After Resection of a Mucinous Neoplasm of the Appendix ». Anticancer Research 35(9): 4943‑47.
  26. « IV. Les recommandations ». 2014. Journal de Chirurgie Viscérale 151(6): S15‑63. doi:10.1016/S1878-786X(14)70198-6.
  27. Iversen, L. H., P. C. Rasmussen, et S. Laurberg. 2013. « Value of Laparoscopy before Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Carcinomatosis ». The British Journal of Surgery 100(2): 285‑92. doi:10.1002/bjs.8908.
  28. Jacquet, P., et P. H. Sugarbaker. 1996. « Clinical Research Methodologies in Diagnosis and Staging of Patients with Peritoneal Carcinomatosis ». Cancer Treatment and Research 82: 359‑74.
  29. Kusamura, S, V Kepenekian, L Villeneuve, RJ Lurvink, K Govaerts, IHJT De Hingh, BJ Moran, et al. 2021. « Peritoneal Mesothelioma: PSOGI/EURACAN Clinical Practice Guidelines for Diagnosis, Treatment and Follow-Up. » Eur J Surg Oncol 47: 36‑59. doi:10.1016/j.ejso.2020.02.011.
  30. Kusamura, Shigeki, Aditi Bhatt, Kurt van Der Speeten, Vahan Kepenekian, Martin Hübner, Clarisse Eveno, Ignace de Hingh, et al. 2024. « Review of 2022 PSOGI/RENAPE consensus on HIPEC ». J. Surg. Oncol. doi:10.1002/jso.27885.
  31. Kusamura, Shigeki, Jean-Baptiste Delhorme, Abdelkader Taibi, Laurent Villeneuve, Marcello Deraco, Rea Lo Dico, Olivier Glehen, et Brendan Moran. 2024. « The 2022 PSOGI international consensus on HIPEC regimens for peritoneal malignancies: Pseudomyxoma peritonei ». Ann. Surg. Oncol. 31(9): 6262‑73. doi:10.1245/s10434-024-15646-6.
  32. Legué, Laura M., Geert-Jan Creemers, Ignace H. J. T. de Hingh, Valery E. P. P. Lemmens, et Clément J. Huysentruyt. 2019. « Review: Pathology and Its Clinical Relevance of Mucinous Appendiceal Neoplasms and Pseudomyxoma Peritonei ». Clinical Colorectal Cancer 18(1): 1‑7. doi:10.1016/j.clcc.2018.11.007.
  33. Lieu, C. H., L. A. Lambert, R. A. Wolff, C. Eng, N. Zhang, S. Wen, S. Rafeeq, et al. 2012. « Systemic Chemotherapy and Surgical Cytoreduction for Poorly Differentiated and Signet Ring Cell Adenocarcinomas of the Appendix ». Annals of Oncology: Official Journal of the European Society for Medical Oncology 23(3): 652‑58. doi:10.1093/annonc/mdr279.
  34. Lo, Nelson S. F., et Michael G. Sarr. 2003. « Mucinous Cystadenocarcinoma of the Appendix. The Controversy Persists: A Review ». Hepato-Gastroenterology 50(50): 432‑37.
  35. Low, Russell N., Robert M. Barone, Jonathan M. Gurney, et Wayne D. Muller. 2008. « Mucinous Appendiceal Neoplasms: Preoperative MR Staging and Classification Compared with Surgical and Histopathologic Findings ». AJR. American journal of roentgenology 190(3): 656‑65. doi:10.2214/AJR.07.2018.
  36. Low, Russell N., Robert M. Barone, et Janelle Lucero. 2015. « Comparison of MRI and CT for Predicting the Peritoneal Cancer Index (PCI) Preoperatively in Patients Being Considered for Cytoreductive Surgical Procedures ». Annals of Surgical Oncology 22(5): 1708‑15. doi:10.1245/s10434-014-4041-7.
  37. Lurvink, R. J., L. Villeneuve, K. Govaerts, I. H. J. T. de Hingh, B. J. Moran, M. Deraco, K. Van der Speeten, et al. 2019. « The Delphi and GRADE Methodology Used in the PSOGI 2018 Consensus Statement on Pseudomyxoma Peritonei and Peritoneal Mesothelioma ». European Journal of Surgical Oncology: The Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology. doi:10.1016/j.ejso.2019.03.012.
  38. Martín-Román, L., P. Lozano, W. Vásquez, N. Palencia, Y. Gómez, M. J. Fernández-Aceñero, et L. González-Bayón. 2021. « Defining Stage in Mucinous Tumours of the Appendix with Peritoneal Dissemination: The Importance of Grading Terminology: Systematic Review ». BJS open 5(4): zrab059. doi:10.1093/bjsopen/zrab059.
  39. McDonald, J. R., S. T. O’Dwyer, S. Rout, B. Chakrabarty, K. Sikand, P. E. Fulford, M. S. Wilson, et A. G. Renehan. 2012. « Classification of and Cytoreductive Surgery for Low-Grade Appendiceal Mucinous Neoplasms ». The British Journal of Surgery 99(7): 987‑92. doi:10.1002/bjs.8739.
  40. Mehta, Akash, Rohin Mittal, Kandiah Chandrakumaran, Norman Carr, Sanjeev Dayal, Faheez Mohamed, Brendan Moran, et Tom Cecil. 2017. « Peritoneal Involvement Is More Common Than Nodal Involvement in Patients With High-Grade Appendix Tumors Who Are Undergoing Prophylactic Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy ». Diseases of the Colon and Rectum 60(11): 1155‑61. doi:10.1097/DCR.0000000000000869.
  41. Menassel, B., A. Duclos, G. Passot, A. Dohan, C. Payet, S. Isaac, P. J. Valette, O. Glehen, et P. Rousset. 2016. « Preoperative CT and MRI Prediction of Non-Resectability in Patients Treated for Pseudomyxoma Peritonei from Mucinous Appendiceal Neoplasms ». European Journal of Surgical Oncology: The Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 42(4): 558‑66. doi:10.1016/j.ejso.2016.01.005.
  42. Milovanov, V., A. Sardi, N. Aydin, C. Nieroda, M. Sittig, M. Nunez, et V. Gushchin. 2015. « Extensive Surgical History Prior to Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Is Associated with Poor Survival Outcomes in Patients with Peritoneal Mucinous Carcinomatosis of Appendiceal Origin ». European Journal of Surgical Oncology: The Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 41(7): 881‑85. doi:10.1016/j.ejso.2015.02.016.
  43. Misdraji, Joseph, Gregory Y. Lauwers, Julie A. Irving, Kenneth P. Batts, et Robert H. Young. 2014. « Appendiceal or Cecal Endometriosis with Intestinal Metaplasia: A Potential Mimic of Appendiceal Mucinous Neoplasms ». The American Journal of Surgical Pathology 38(5): 698‑705. doi:10.1097/PAS.0000000000000167.
  44. Moulton, Carol-Anne, Chu-Shu Gu, Calvin H. Law, Ved R. Tandan, Richard Hart, Douglas Quan, Robert J. Fairfull Smith, et al. 2014. « Effect of PET before Liver Resection on Surgical Management for Colorectal Adenocarcinoma Metastases: A Randomized Clinical Trial ». JAMA 311(18): 1863‑69. doi:10.1001/jama.2014.3740.
  45. Munoz-Zuluaga, Carlos A., Mary Caitlin King, Panayotis Ledakis, Vadim Gushchin, Michelle Sittig, Carol Nieroda, Katherine Zambrano-Vera, et Armando Sardi. 2019. « Systemic Chemotherapy before Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (CRS/HIPEC) in Patients with High-Grade Mucinous Carcinoma Peritonei of Appendiceal Origin ». European Journal of Surgical Oncology: The Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 45(9): 1598‑1606. doi:10.1016/j.ejso.2019.05.008.
  46. Murphy, E. M. A., S. M. Farquharson, et B. J. Moran. 2006. « Management of an Unexpected Appendiceal Neoplasm ». The British Journal of Surgery 93(7): 783‑92. doi:10.1002/bjs.5385.
  47. Nishikawa, G., S. Sekine, R. Ogawa, A. Matsubara, T. Mori, H. Taniguchi, R. Kushima, et al. 2013. « Frequent GNAS Mutations in Low-Grade Appendiceal Mucinous Neoplasms ». British Journal of Cancer 108(4): 951‑58. doi:10.1038/bjc.2013.47.
  48. Omohwo, Cyril, Carol A. Nieroda, Kimberley D. Studeman, Heather Thieme, Paula Kostuik, Alexander S. Ross, Darlene R. Holter, et al. 2009. « Complete Cytoreduction Offers Longterm Survival in Patients with Peritoneal Carcinomatosis from Appendiceal Tumors of Unfavorable Histology ». Journal of the American College of Surgeons 209(3): 308‑12. doi:10.1016/j.jamcollsurg.2009.04.019.
  49. Pietrantonio, Filippo, Claudia Maggi, Giuseppe Fanetti, Roberto Iacovelli, Maria Di Bartolomeo, Francesca Ricchini, Marcello Deraco, et al. 2014. « FOLFOX-4 Chemotherapy for Patients with Unresectable or Relapsed Peritoneal Pseudomyxoma ». The Oncologist 19(8): 845‑50. doi:10.1634/theoncologist.2014-0106.
  50. Reid, Michelle D., Olca Basturk, Walid L. Shaib, Yue Xue, Serdar Balci, Hye-Jeong Choi, Gizem Akkas, et al. 2016. « Adenocarcinoma Ex-Goblet Cell Carcinoid (Appendiceal-Type Crypt Cell Adenocarcinoma) Is a Morphologically Distinct Entity with Highly Aggressive Behavior and Frequent Association with Peritoneal/Intra-Abdominal Dissemination: An Analysis of 77 Cases ». Modern Pathology: An Official Journal of the United States and Canadian Academy of Pathology, Inc 29(10): 1243‑53. doi:10.1038/modpathol.2016.105.
  51. Shaib, Walid L., Ludmila Katherine Martin, Minsing Choi, Zhengjia Chen, Kavya Krishna, Sungjin Kim, Edith Brutcher, et al. 2015. « Hyperthermic Intraperitoneal Chemotherapy Following Cytoreductive Surgery Improves Outcome in Patients With Primary Appendiceal Mucinous Adenocarcinoma: A Pooled Analysis From Three Tertiary Care Centers ». The Oncologist 20(8): 907‑14. doi:10.1634/theoncologist.2014-0294.
  52. Shapiro, Jamie F., Judy L. Chase, Robert A. Wolff, Laura A. Lambert, Paul F. Mansfield, Michael J. Overman, Aki Ohinata, et al. 2010. « Modern Systemic Chemotherapy in Surgically Unresectable Neoplasms of Appendiceal Origin: A Single-Institution Experience ». Cancer 116(2): 316‑22. doi:10.1002/cncr.24715.
  53. Smeenk, R.M., M.L.F. van Velthuysen, V.J. Verwaal, et F.A.N. Zoetmulder. 2008. « Appendiceal Neoplasms and Pseudomyxoma Peritonei: A Population Based Study ». European Journal of Surgical Oncology (EJSO) 34(2): 196‑201. doi:10.1016/j.ejso.2007.04.002.
  54. Sugarbaker, Paul H. 2017. « When and When Not to Perform a Right Colon Resection with Mucinous Appendiceal Neoplasms ». Annals of Surgical Oncology 24(3): 729‑32. doi:10.1245/s10434-016-5632-2.
  55. Sugarbaker, Paul H., Lana Bijelic, David Chang, et Dal Yoo. 2010. « Neoadjuvant FOLFOX Chemotherapy in 34 Consecutive Patients with Mucinous Peritoneal Carcinomatosis of Appendiceal Origin ». Journal of Surgical Oncology 102(6): 576‑81. doi:10.1002/jso.21679.
  56. Trivedi, Apurva N., Edward A. Levine, et Girish Mishra. 2009. « Adenocarcinoma of the Appendix Is Rarely Detected by Colonoscopy ». Journal of Gastrointestinal Surgery: Official Journal of the Society for Surgery of the Alimentary Tract 13(4): 668‑75. doi:10.1007/s11605-008-0774-6.
  57. Van der Speeten, Kurt, Shigeki Kusamura, Laurent Villeneuve, Pompiliu Piso, Vic J. Verwaal, Santiago González-Moreno, et Olivier Glehen. 2024. « The 2022 PSOGI International Consensus on HIPEC Regimens for Peritoneal Malignancies: HIPEC Technologies ». Annals of Surgical Oncology 31(10): 7090‑7110. doi:10.1245/s10434-024-15513-4.
  58. Weitz, Jonathan, Daisuke Nishizaki, Joy Liau, Jay Patel, Isabella Ng, Siming Sun, Dana Ramms, et al. 2025. « Cyclin-Dependent Kinase 4/6 Inhibition as a Novel Therapy for Peritoneal Mucinous Carcinomatosis With GNAS Mutations ». Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 43(6): 705‑15. doi:10.1200/JCO.24.00511.
  59. Zhang, Yingtao, Muhammad Zulfiqar, Martin H. Bluth, Amarpreet Bhalla, et Rafic Beydoun. 2018. « Molecular Diagnostics in the Neoplasms of Small Intestine and Appendix: 2018 Update ». Clinics in Laboratory Medicine 38(2): 343‑55. doi:10.1016/j.cll.2018.03.002.
  60. 1. WHO Classification of Tumors – Digestive system Tumors 5th edition 2019